Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of GemCis Plus Trastuzumab Plus Pembrolizumab in Previously Untreated HER2-positive Biliary Tract Cancer	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, gallbladder disorder, gallbladder neoplasm, neoplasm	Active, not recruiting	Phase 2	2026-03-27		NCT06178445

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest	34
Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel	1
MSD Sharp & Dohme GmbH, Germany	2

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Charité Universitätsmedizin	Berlin	Germany	5
Hämatologisch-Onkologische Praxis Eppendorf (HOPE)	Hamburg	Germany	1
Krankenhaus Nordwest (KHNW)	Frankfurt	Germany	1
LMU München	München	Germany	2
Medizinische Hochschule Hannover	Hanover	Germany	42
Universitätsklinikum Augsburg	Augsburg	Germany	15
Universitätsklinikum Freiburg	Freiburg im Breisgau	Germany	14
Universitätsklinikum Göttingen	Göttingen	Germany	5